Primary ADT not Associated with Improved OS for Localized PCa

Primary ADT is not Associated with Improved Long-term Overall or Disease-specific Survival for Men with Localized Prostate Cancer - Perspectives from the Editor-in-Chief (July 2014)

Thomas E. Keane, MD

Related Content:

Click HERE to read the abstract for Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

Click HERE to listen to an interview with Siu-Long Yao, MD, one of the authors of the article Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer 

Click HERE to view the poster for Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe